VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ATEC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ATECAlphatec Holdings, Inc.
$7.44$1.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksATECFinancials

Alphatec Holdings, Inc. (ATEC) Income Statement

22Y historyFree accessUpdated daily

Revenue reached $221.2M in 2026Q3 with gross margin of 71.5%, yet a net loss of $5.5M and SBC of $14.0M indicate that operating breakeven has not yet translated into durable bottom-line earnings.

Income StatementBalance SheetCash FlowRatios

ATEC Income Statement

Annual statement

ATEC Income Statement

Alphatec Holdings, Inc. (ATEC) annual income statement — 22-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04
Sales/Revenue839.72M764.15M611.56M482.26M350.87M243.21M144.86M113.43M91.69M101.74M120.25M185.28M206.98M204.72M196.28M197.71M171.61M132.16M101.31M80.03M74M42.33M17.82M
Revenue Growth %15.34%24.95%26.81%37.45%44.26%67.89%27.71%23.7%-9.87%-15.39%-35.1%-10.48%1.1%4.3%-0.72%15.21%29.85%30.44%26.59%8.14%74.85%137.5%-
Cost of Goods Sold279.65M232.27M187.3M172.06M117.81M85.45M42.36M35.83M28.46M39.41M44.11M63.74M61.83M78.67M70.76M80.78M58.79M48.02M36.6M29.82M25.7M17.72M5.46M
COGS % of Revenue-30.4%30.63%35.68%33.58%35.13%29.24%31.59%31.03%38.73%36.69%34.4%29.87%38.43%36.05%40.86%34.26%36.33%36.13%37.27%34.73%41.87%30.64%
Gross Profit560.07M531.89M424.26M310.2M233.06M157.76M102.5M77.59M63.24M62.33M76.13M121.54M145.15M126.06M125.52M116.93M112.82M84.14M64.71M50.21M48.3M24.6M12.36M
Gross Margin %66.7%69.6%69.37%64.32%66.42%64.87%70.76%68.41%68.97%61.27%63.31%65.6%70.13%61.57%63.95%59.14%65.74%63.67%63.87%62.73%65.27%58.13%69.36%
Gross Profit Growth %-25.37%36.77%33.1%47.73%53.91%32.1%22.7%1.45%-18.13%-37.36%-16.27%15.14%0.43%7.34%3.65%34.08%30.03%28.88%3.94%96.33%99.04%-
Operating Expenses586.16M614.02M560.43M483.6M380.03M285.82M161.36M124.87M83.23M69.99M87.48M127.62M142.6M143.84M134.27M130.6M122.22M87.31M89.76M60.55M70.42M39.65M12.18M
OpEx % of Revenue-80.35%91.64%100.28%108.31%117.52%111.39%110.09%90.77%68.79%72.75%68.88%68.89%70.26%68.41%66.05%71.22%66.07%88.6%75.66%95.15%93.67%68.36%
Selling, General & Admin517.03M498.53M450.2M374.08M300.01M229.27M129.16M101.71M72.51M64.38M77.3M105.72M120.56M124.91M115.12M111.56M101.29M73.83M65.8M54.19M66.83M35.58M11.01M
SG&A % of Revenue-65.24%73.61%77.57%85.51%94.27%89.16%89.67%79.08%63.28%64.28%57.06%58.25%61.01%58.65%56.42%59.02%55.86%64.95%67.71%90.3%84.06%61.76%
Research & Development76.47M76.27M80.72M70.11M44.03M32.02M18.75M13.85M9.98M4.92M9.25M18.04M17.33M14.19M15.23M16.89M19.4M13.49M12.96M6.36M3.59M4.07M1.18M
R&D % of Revenue-9.98%13.2%14.54%12.55%13.16%12.94%12.21%10.89%4.84%7.69%9.74%8.37%6.93%7.76%8.54%11.3%10.21%12.8%7.95%4.85%9.61%6.6%
Other Operating Expenses1000K39.22M29.51M39.4M35.99M24.53M13.46M9.31M738K0-715K6.98M-33K-1.66M-794K2.15M1.53M000000
Operating Income-26.08M-82.13M-136.17M-173.4M-146.97M-128.06M-58.86M-47.28M-22.44M-9M-15.38M-172.44M1.84M-73.43M-9.84M-24.52M-11.79M-9.56M-27.81M-19.69M-22.11M-15.04M177.81K
Operating Margin %-3.11%-10.75%-22.27%-35.95%-41.89%-52.65%-40.63%-41.68%-24.47%-8.85%-12.79%-93.07%0.89%-35.87%-5.01%-12.4%-6.87%-7.23%-27.45%-24.6%-29.88%-35.54%1%
Operating Income Growth %-39.69%21.47%-17.98%-14.77%-117.55%-24.51%-110.68%-149.25%41.45%91.08%-9451.36%102.51%-646.5%59.88%-107.96%-23.35%65.63%-41.25%10.98%-47%-8560.46%-
EBITDA56.45M435K-52.85M-113.71M-103.05M-97.88M-47.23M-38.77M-15.65M-1.52M-3.01M-168.59M6.55M-68.69M-5.91M-22.36M-10.25M2.4M-19.07M-9.06M-13.1M-11.5M811.66K
EBITDA Margin %6.72%0.06%-8.64%-23.58%-29.37%-40.25%-32.6%-34.18%-17.07%-1.5%-2.51%-90.99%3.17%-33.55%-3.01%-11.31%-5.98%1.82%-18.83%-11.33%-17.7%-27.18%4.55%
EBITDA Growth %513.9%100.82%53.52%-10.35%-5.28%-107.24%-21.83%-147.7%-928.32%49.49%98.21%-2672.26%109.54%-1062.68%73.58%-118.1%-527.43%112.58%-110.42%30.8%-13.87%-1517.24%-
D&A (Non-Cash Add-back)82.53M82.56M83.32M59.68M43.93M30.17M11.63M8.51M6.79M7.48M12.36M3.85M4.71M4.74M3.93M2.15M1.53M11.96M8.73M10.62M9.02M3.54M633.85K
EBIT-50.21M-122.26M-137.19M-170.27M-146.5M-137.05M-66.47M-47.28M-23.03M3.04M-25.57M-168.4M3.33M-75.09M-10.51M-23.66M-10.54M-9.92M-26.95M-18.74M-22.11M-15.04M917.09K
Net Interest Income-38.48M-21.14M-24.88M-16.64M-5.5M-7.11M-12.37M-9.87M-7.14M-7.62M-5.37M-3.99M-3.01M-3.95M-5.99M-2.88M-5.87M-3.4M-1.5M-75K-1.43M-1.93M-311.51K
Interest Income00000009.87M00011K10K6K118K148K81K67K374K793K701K00
Interest Expense38.48M21.14M24.88M16.64M5.5M7.11M12.37M07.14M7.62M5.37M4M3.02M3.96M6.11M3.03M4.7M3.49M1.88M868K2.13M1.93M311.51K
Other Income/Expense-62.61M-61.27M-25.9M-13.52M-5.03M-16.11M-19.99M-9.87M-7.73M4.43M-15.56M3.46M-13.28M-5.62M-1.16M-4.51M-2.05M-9.87M-1.01M74K-3.43M-2.05M427.77K
Pretax Income-88.69M-143.4M-162.07M-186.91M-152.01M-144.16M-78.85M-57.14M-30.17M-4.57M-30.93M-178M-11.79M-79.05M-16.62M-26.69M-16.49M-13.05M-28.82M-19.61M-25.55M-17.09M605.58K
Pretax Margin %-10.56%-18.77%-26.5%-38.76%-43.32%-59.27%-54.43%-50.38%-32.9%-4.5%-25.73%-96.07%-5.7%-38.61%-8.47%-13.5%-9.61%-9.87%-28.45%-24.51%-34.52%-40.38%3.4%
Income Tax-1.81M-45K50K-277K-716K-1.13M145K-239K-1.36M-34K-4.49M681K1.09M3.18M-1.16M-4.51M-2.05M243K468K590K270K-3.04M96.13K
Effective Tax Rate %2.04%0.03%-0.03%0.15%0.47%0.78%-0.18%0.42%4.51%0.74%14.51%-0.38%-9.22%-4.02%6.97%16.89%12.46%-1.86%-1.62%-3.01%-1.06%17.77%15.87%
Net Income-86.89M-143.36M-162.12M-186.64M-151.29M-143.03M-78.99M-57M-28.98M-2.29M-30.32M-178.68M-12.88M-82.23M-15.46M-22.18M-14.36M-13.29M-29.29M-20.2M-25.82M-14.05M509.45K
Net Margin %-10.35%-18.76%-26.51%-38.7%-43.12%-58.81%-54.53%-50.25%-31.6%-2.25%-25.21%-96.44%-6.22%-40.16%-7.88%-11.22%-8.36%-10.06%-28.91%-25.24%-34.88%-33.2%2.86%
Net Income Growth %43.93%11.57%13.14%-23.36%-5.78%-81.07%-38.58%-96.73%-1163.08%92.43%83.03%-1287.02%84.33%-431.9%30.31%-54.52%-8.02%54.63%-44.98%21.75%-83.69%-2858.67%-
Net Income (Continuing)-86.89M-143.36M-162.12M-186.64M-151.29M-143.03M-78.99M-56.9M-28.81M-4.54M-26.3M-171.25M-98K-82.23M-15.46M-22.18M-14.43M-13.29M-29.29M-20.2M-25.82M-14.05M509.45K
Discontinued Operations0000000-100K02.25M0000000000000
Minority Interest000000000000000000002.72M1.91M0
EPS (Diluted)-0.55-0.96-1.13-1.54-1.47-1.50-1.18-1.09-0.82-0.17-3.53-21.53-1.58-10.25-2.06-3.00-2.19-3.24-7.59-6.50-11.37-9.270.60
EPS Growth %46.15%15.04%26.62%-4.76%2%-27.12%-8.26%-32.93%-382.35%95.18%83.6%-1262.66%84.59%-397.57%31.33%-36.99%32.41%57.31%-16.77%42.83%-22.65%-1645%-
EPS (Basic)--0.96-1.13-1.54-1.47-1.50-1.18-1.09-0.82-0.18-3.53-21.53-1.59-10.25-2.06-3.00-2.19-3.24-7.59-6.50-11.37-9.270.72
Diluted Shares Outstanding157.38M150.06M142.95M121.24M103.37M96.2M67.02M52.23M35.31M13.28M8.58M8.3M8.14M8.02M7.52M7.4M6.55M4.11M3.86M3.11M2.27M1.18M801.69K
Basic Shares Outstanding157.38M150.06M142.95M121.24M103.37M96.2M67.02M52.23M35.31M12.79M8.58M8.3M8.11M8.02M7.52M7.4M6.55M4.11M3.86M3.11M2.27M1.16M764.9K
Dividend Payout Ratio-----------------------

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Persistent operating losses and leverage

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Top-Line Growth Decelerating From Peak

Based on the reported quarterly income statement, ATEC's revenue grew about 12.6% year over year in the most recent quarter, down from 30.4% in 2025Q3, suggesting growth is normalizing as the case-volume base scales and incremental share gains become harder to win.

Revenue rose from $145.6M in 2024Q2 to $221.2M in 2026Q3, a strong multi-year expansion, but the sequential pattern shows growth decelerating from the high twenties toward the low-to-mid teens. This pattern may indicate that the PTP and Invictus platforms are maturing within existing hospital accounts, so investors should monitor whether surgeon conversion and EOS placements can sustain growth in the high teens as the revenue base grows.

Gross Margin Recovery Masks Operating Drag

Reported gross margin recovered from 61.1% in 2026Q1 to 71.5% in 2026Q3, returning to levels seen in 2024, which suggests pricing and mix are supporting unit economics even as the company remains loss-making below the gross line.

The gross margin trough in late 2025 and early 2026 appears tied to either mix shift or inventory-related effects, though the reported figures do not isolate the cause. The recovery to roughly 71% indicates that the implant and biologics franchise retains pricing power, yet the operating margin of only 1.5% in the latest quarter shows that SG&A, at roughly 60% of revenue, absorbs nearly all of the gross profit.

SG&A Absorbs Nearly All Gross Profit

Based on ATEC's reported figures, SG&A of $132.5M in 2026Q3 consumed about 84% of gross profit of $158.2M, indicating that operating leverage is only beginning to emerge after years of heavy commercial investment.

Operating income moved from a loss of $44.3M in 2025Q1 to a small profit of $3.2M in 2026Q3, which suggests gross profit growth is outpacing SG&A growth at the margin. However, SG&A has remained in a narrow $109M to $137M band across the period while revenue grew substantially, which implies the leverage is real but still thin. Investors should watch whether SG&A growth stays below revenue growth for several more quarters before treating this as durable.

Net Loss Persists Despite Operating Breakeven

As reported in the quarterly statements, ATEC posted a net loss of $5.5M in 2026Q3 despite positive operating income of $3.2M, and stock-based compensation of $14.0M suggests non-operating charges and SBC weigh on reported earnings quality.

The gap between operating income and net income points to interest expense and other non-operating items, consistent with a leveraged balance sheet with a reported debt-to-equity ratio of 17.21. Stock-based compensation has run between $14M and $24M per quarter, a significant non-cash burden that flatters cash profitability relative to GAAP results. The EPS trajectory, from -$0.35 to -$0.03, is improving but remains negative, so reported earnings should not yet be viewed as a clean signal of sustainable profitability.

Growth Durability and Leverage Risks

The strongest bear case rests on the reported -630.7% ROE and debt-to-equity of 17.21, which suggests the company's growth must continue to outrun financing costs and dilution, a difficult condition if revenue growth keeps slowing from 30% toward the mid-teens.

Short-sellers would likely argue that the recent gross margin recovery and operating breakeven are fragile, given that a single quarter's improvement followed a year of deep losses. If case volume growth slows further or hospital capital budgets tighten, the high fixed SG&A base could push operating margins back into negative territory quickly. The lack of disclosed EPS against consensus for the latest period also warrants caution before assuming the profitability inflection is established.

ATEC — Frequently Asked Questions

Quick answers to the most common questions about buying ATEC stock.

What was Alphatec Holdings, Inc.'s (ATEC) revenue in 2025?

For fiscal year 2025, Alphatec Holdings, Inc. (ATEC) reported total revenue of $764.2M. This represents a 4187.9% increase compared to $17.8M in 2004.

Is Alphatec Holdings, Inc. (ATEC) profitable?

Alphatec Holdings, Inc. (ATEC) reported a net loss of $143.4M for the fiscal year ending 2025.

What is Alphatec Holdings, Inc.'s operating profit margin?

Alphatec Holdings, Inc. (ATEC) reported an operating income of $-82.1M, resulting in an operating profit margin of -10.7%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Alphatec Holdings, Inc.'s gross profit and gross margin?

Alphatec Holdings, Inc. (ATEC) generated $531.9M in gross profit for the year, representing a gross profit margin of 69.6%. This demonstrates the company's core pricing power and production efficiency.